Vol 79, Supp. IV (2021): Zeszyty Edukacyjne 4/2021
Opinie i stanowiska ekspertów
Published online: 2021-11-26
Page views
6980
Article views/downloads
11080
Przezcewnikowa naprawa i wymiana zastawki mitralnej. Stanowisko Ekspertów Polskiego Towarzystwa Kardiologicznego oraz Polskiego Towarzystwa Kardio-Torakochirurgów
DOI: 10.33963/v.kp.87140
Abstract
Not available
References
- Petrus AHJ, Dekkers OM, Tops LF, et al. Impact of recurrent mitral regurgitation after mitral valve repair for functional mitral regurgitation: long-term analysis of competing outcomes. Eur Heart J. 2019; 40(27): 2206–2214.
- Orban M, Rommel KP, Ho EC, et al. Transcatheter edge-to-edge tricuspid repair for severe tricuspid regurgitation reduces hospitalizations for heart failure. JACC Heart Fail. 2020; 8(4): 265–276.
- Mehr M, Karam N, Taramasso M, et al. TriValve and TRAMI Investigators. Combined tricuspid and mitral versus isolated mitral valve repair for severe mr and TR: an analysis from the trivalve and TRAMI registries. JACC Cardiovasc Interv. 2020; 13(5): 543–550.
- Del Val D, Ferreira-Neto AN, Wintzer-Wehekind J, et al. Early experience with transcatheter mitral valve replacement: a systematic review. J Am Heart Assoc. 2019; 8(17): e013332.
- Baumgartner H, Falk V, Bax JJ, et al. ESC Scientific Document Group. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017; 38(36): 2739–2791.
- Feldman T, Wasserman HS, Herrmann HC, et al. Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I Clinical Trial. J Am Coll Cardiol. 2005; 46(11): 2134–2140.
- Feldman T, Foster E, Glower DD, et al. EVEREST II Investigators. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med. 2011; 364(15): 1395–1406.
- Mack MJ, Lindenfeld J, Abraham WT, et al. COAPT Investigators. 3-year outcomes of transcatheter mitral valve repair in patients with heart failure. J Am Coll Cardiol. 2021; 77(8): 1029–1040.
- Feldman T, Kar S, Elmariah S, et al. EVEREST II Investigators. Randomized comparison of percutaneous repair and surgery for mitral regurgitation: 5-year results of EVEREST II. J Am Coll Cardiol. 2015; 66(25): 2844–2854.
- Obadia JF, Messika-Zeitoun D, Leurent G, et al. Percutaneous repair or medical treatment for secondary mitral regurgitation. N Engl J Med. 2018; 379(24): 2297–2306.
- Stone GW, Lindenfeld J, Abraham WT, et al. Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med. 2018; 379(24): 2307–2318.
- Pibarot P, Delgado V, Bax JJ. MITRA-FR vs. COAPT: lessons from two trials with diametrically opposed results. Eur Heart J Cardiovasc Imaging. 2019; 20(6): 620–624.
- Maisano F, Franzen O, Baldus S, et al. Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe. J Am Coll Cardiol. 2013; 62(12): 1052–1061.
- Kalbacher D, Schäfer U, V Bardeleben RS, et al. Long-term outcome, survival and predictors of mortality after MitraClip therapy: Results from the German Transcatheter Mitral Valve Interventions (TRAMI) registry. Int J Cardiol. 2019; 277: 35–41.
- Gammie JS, Wilson P, Bartus K, et al. Transapical beating-heart mitral valve repair with an expanded polytetrafluoroethylene cordal implantation device: initial clinical experience. Circulation. 2016; 134(3): 189–197.
- Attizzani GF, Ohno Y, Capodanno D, et al. Extended use of percutaneous edge-to-edge mitral valve repair beyond EVEREST (Endovascular Valve Edge-to-Edge Repair) criteria: 30-day and 12-month clinical and echocardiographic outcomes from the GRASP (Getting Reduction of Mitral Insufficiency by Percutaneous Clip Implantation) registry. JACC Cardiovasc Interv. 2015; 8(1 Pt A): 74–82.
- Grasso C, Capodanno D, Scandura S, et al. One- and twelve-month safety and efficacy outcomes of patients undergoing edge-to-edge percutaneous mitral valve repair (from the GRASP Registry). Am J Cardiol. 2013; 111(10): 1482–1487.
- Horn P, Hellhammer K, Minier M, et al. Deep sedation vs. general anesthesia in 232 patients undergoing percutaneous mitral valve repair using the MitraClip system. Catheter Cardiovasc Interv. 2017; 90(7): 1212–1219.
- Takagi H, Ando T, Umemoto T, et al. ALICE (All-Literature Investigation of Cardiovascular Evidence) Group. A review of comparative studies of MitraClip versus surgical repair for mitral regurgitation. Int J Cardiol. 2017; 228: 289–294.
- Besler C, Noack T, von Roeder M, et al. Transcatheter edge-to-edge mitral valve repair with the PASCAL system: early results from a real-world series. EuroIntervention. 2020; 16(10): 824–832.
- Yeo KK, Yap J, Tan JW, et al. Venous access closure using the double-proglide preclose technique after mitraclip implantation: long-term clinical and duplex ultrasound outcomes. J Invasive Cardiol. 2016; 28(2): 40–43.
- MitraClip provides valve repair without surgery. Harv Heart Lett. 2014; 24(6): 8.
- Schueler R, Öztürk C, Wedekind JA, et al. Persistence of iatrogenic atrial septal defect after interventional mitral valve repair with the MitraClip system: a note of caution. JACC Cardiovasc Interv. 2015; 8(3): 450–459.
- Morikawa T, Miyasaka M, Flint N, et al. Right-to-Left shunt through iatrogenic atrial septal defect after mitraclip procedure. JACC Cardiovasc Interv. 2020; 13(13): 1544–1553.
- Kadado AJ, Islam A. Iatrogenic atrial septal defect following the MitraClip procedure: A state-of-the-art review. Catheter Cardiovasc Interv. 2021; 97(7): E1043–E1052.
- Lurz P, Unterhuber M, Rommel KP, et al. Closure of iatrogenic atrial septal defect after transcatheter mitral valve repair: the randomized MITHRAS trial. Circulation. 2021; 143(3): 292–294.
- von Bardeleben RS, Hobohm L, Kreidel F, et al. Incidence and in-hospital safety outcomes of patients undergoing percutaneous mitral valve edge-to-edge repair using MitraClip: five-year German national patient sample including 13,575 implants. EuroIntervention. 2019; 14(17): 1725–1732.
- Isogai T, Saad AM, Shekhar S, et al. Incidence and short-term outcomes of surgical bailout after transcatheter mitral valve repair with the MitraClip system. Catheter Cardiovasc Interv. 2021; 97(2): 335–341.
- Thomas F, Rader F, Siegel RJ. The use of MitraClip for symptomatic patients with hypertrophic obstructive cardiomyopathy. Cardiology. 2017; 137(1): 58–61.
- Płońska-Gościniak E, Suwalski P, Bartuś S, et al. Management of valvular and structural heart diseases during the coronavirus disease 2019 pandemic: an expert opinion of the Working Group on Valvular Heart Diseases, the Working Group on Cardiac Surgery, and the Association of Cardiovascular Interventions of the Polish Cardiac Society. Kardiol Pol. 2020; 78(5): 498–507.
- Siminiak T, Wu JC, Haude M, et al. Treatment of functional mitral regurgitation by percutaneous annuloplasty: results of the TITAN Trial. Eur J Heart Fail. 2012; 14(8): 931–938.
- Witte KK, Lipiecki J, Siminiak T, et al. The REDUCE FMR trial: a randomized sham-controlled study of percutaneous mitral annuloplasty in functional mitral regurgitation. JACC Heart Fail. 2019; 7(11): 945–955.
- Messika-Zeitoun D, Nickenig G, Latib A, et al. Transcatheter mitral valve repair for functional mitral regurgitation using the Cardioband system: 1 year outcomes. Eur Heart J. 2019; 40(5): 466–472.
- Colli A, Manzan E, Aidietis A, et al. An early European experience with transapical off-pump mitral valve repair with NeoChord implantation. Eur J Cardiothorac Surg. 2018; 54(3): 460–466.
- Gammie JS, Bartus K, Gackowski A, et al. Beating-heart mitral valve repair using a novel ePTFE cordal implantation device: a prospective trial. J Am Coll Cardiol. 2018; 71(1): 25–36.
![](https://journals.viamedica.pl/plugins/generic/popups/images/icons/close.png)